Ignore This Picture
Spacer
faculty photo

Gary R. Lichtenstein, M.D.

Professor of Medicine at the Hospital of the University of Pennsylvania
Director, IBD Program, Hospital of the University of Pennsylvania
Department: Medicine

Contact information
Hospital of the University of Pennsylvania
7th Floor Perelman Center, 7-South Perelman Center, Room 753
Gastroentetrology Division Offices
One Convention Avenue
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Education:
BA (Chemistry)
University of Pennsylvania, 1980.
MD
Mount Sinai School of Medicine, 1984.
Post-Graduate Training
Intern in Medicine, Duke University Medical Center, 1984-1985.
Resident in Medicine, Duke University Medical Center, 1985-1987.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, 1987-1990.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

My research focuses on inflammatory bowel disease specifically Crohn's disease and Ulcerative Colitis. My particular focuses include
1.) medical therapy of inflammatory bowel disease,
2.) safety of current medical therapy for IBD, and
3.) natural history of disease

Description of Clinical Expertise

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis

Selected Publications

Kotlyar D, Lewis JD, Beaugerie L,Tierney A, Brensinger CM, Gisbert, JP, Loftus E, Peyrin-Biroulet L, Blonski W, Van Domselaar M, Chaparro, M, Sandilya S, Bewtra M, Lichtenstein GR: Risk of Lymphoma among Inflammatory Bowel Disease Patients Treated with Azathioprine and 6-Mercaptopurine: Meta-Analysis of Referral Center Studies and Population-based Studies. Clinical Gastroenterology and Hepatology 13(5): 847-858, May 2015.

John Wysocki, Gary R. Lichtenstein, Nabeel Khan : Efficacy of Thiopurines in Achieving Steroid Free Remission in Ulcerative Colitis Patients: A Population Cohort Study. Gastroenterology 148(4 Supplement 1): S 867, April 2015.

Prashant R. Mudireddy, Frank I. Scott, Alexandra Feathers, Ann Tierney, Gary R. Lichtenstein: Predictors of Early and Late Unplanned Re-Admissions in IBD Patients. Gastroenterology 148(4 Suppkement 1): S262-S263, April 2015.

Elisabeth B. Cole, Ali Abbas, Gary R. Lichtenstein, Nabeel Khan.: Temporal Relationship Between Onset of Ulcerative Colitis and Diagnosis of Primary Sclerosing Cholangitis: A Nationwide Population Cohort Study. Gastroenterology 148(4 Supplement 1): S-479, April 2015.

Maria Paula Henao, Meenakshi Bewtra, Mark T. Osterman, Faten Aberra, Frank I. Scott, Gary R. Lichtenstein, Jennifer Kraschnewski, James Lewis.: Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection. Gastroenterology 148(4 Supplement 1): S-443, April 2015.

Prashant R. Mudireddy, Frank I. Scott, Gary R. Lichtenstein.: Unplanned Hospital Readmission: Rates and Causes in Patients With Inflammatory Bowel Disease: A Critical Analysis. Gastroenterology 148(4 Supplement 1): S-835, April 2015.

John Wysocki, Gary R. Lichtenstein, Nabeel Khan: Efficacy of Thiopurines in Achieving Mucosal Healing in Ulcerative Colitis Patients: A Population Cohort Analysis. Gastroenterology 148(4 Supplement 1): S-867, April 2015.

Gary R. Lichtenstein, Edward V. Loftus, Brian G. Feagan, David G. Binion, David Sen, Amanda Golembesky, Gordana Kosutic, Cem Kayhan, Marshall Spearman, Douglas C. Wolf, Scott D. Lee. : Evaluation of Real-World Risk of Malignancies in Crohn's Disease Patients Treated With Certolizumab Pegol: Results From the SECURE Registry. Gastroenterology 148(4): S-236, April 2015.

Ravy K. Vajravelu, Mark T. Osterman, Faten Aberra, Gary R. Lichtenstein, James Lewis, Frank I. Scott: Predictors of Indeterminate QuantiFERON-TB Gold Testing in Inflammatory Bowel Disease and Impact on Clinical Outcomes. Gastroenterology 148(4 Supplement 1): S 253, April 2015.

Gary R. Lichtenstein, Brian G. Feagan, William Sandborn, Iram Hasan, Gordana Kosutic, Jason Coarse, Catherine H. Arendt, Marshall Spearman, Edward V. Loftus.: Serious Infectious Complications in Patients Treated With Certolizumab Pegol: A Pooled Analysis of 15 Crohn's Disease Global Clinical Trials. Gastroenterology 148(4 Supplement 1): S-236, April 2015.

back to top
Last updated: 10/30/2015
The Trustees of the University of Pennsylvania
 
Spacer

[Return to faculty list]

Spacer
University of Pennsylvania | School of Medicine